What is Cumberland Pharmaceuticals's total revenue?

Cumberland Pharmaceuticals (CPIX) reported total revenue of $9.13M in Q1 2026.

How has Cumberland Pharmaceuticals's total revenue changed year-over-year?

Cumberland Pharmaceuticals's total revenue decreased by 22.0% year-over-year, from $11.71M to $9.13M.

What is the long-term trend for Cumberland Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's total revenue has grown at a 5.5% compound annual growth rate (CAGR), from $35.99M to $44.52M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Cumberland Pharmaceuticals CPIX Total Revenue

Total Revenue at other companies

Baxter InternationalBAX

$2.7B+2.9%

PTH

Pelthos Therapeutics Inc.PTHS

$10.91M—

Rigel PharmaceuticalsRIGL

$58.82M+10.3%

BridgeBio PharmaBBIO

$194.52M+66.8%

RFL

Rafael Holdings, Inc.RFL

$179K-50.6%

Opko HealthOPK

$124.2M-17.2%

Segments

By product

See full

Kristalose$3.12M-28.7%

Sancuso$2.93M+29.8%

Vibativ$2.12M-29.4%

Talicia$1.92M—

Caldolor$896.71K-34.7%

Other revenue$168.85K-94.6%

By geography

See full

Non-US$4.9M+81.5%

Other financials

Income statement

See full

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+142%

Enterprise value$90.91M+212%

P/S2.3×+1.4×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's total revenue?: Cumberland Pharmaceuticals (CPIX) reported total revenue of $9.13M in Q1 2026.
How has Cumberland Pharmaceuticals's total revenue changed year-over-year?: Cumberland Pharmaceuticals's total revenue decreased by 22.0% year-over-year, from $11.71M to $9.13M.
What is the long-term trend for Cumberland Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's total revenue has grown at a 5.5% compound annual growth rate (CAGR), from $35.99M to $44.52M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.